No Detail Found!

Clinical Efficacy of Ganglioside Combined with Methylprednisolone in the Treatment of Spinal Cord Injury and Its Effect on In ammatory Response and Oxidative Stress Factors

Author(s)
Dongliang Ren Department of Orthopaedics, Baoding No.1 Central Hospital,Baoding, Hebei,China
Hui Li Department of Orthopaedics, Baoding No.1 Central Hospital,Baoding, Hebei,China
Xiangdong Liu Department of Orthopaedics, Baoding No.1 Central Hospital,Baoding, Hebei,China
Meihua Wang Department of Orthopaedics, Baoding No.1 Central Hospital,Baoding, Hebei,China
Abstract
Objective: To determine the clinical e cacy of monosialotetrahexosylganglioside (GM1) combined with methylprednisolone in the treatment of spinal cord injury (SCI). Study Design: An observational study. Place and Duration of the Study: Department of Orthopaedics, Baoding No.1 Central Hospital, Baoding, Hebei, China,from January 2018 to June 2021. Methodology: A total of 80 patients with SCI were divided into control and observation groups according to treatment methods, the control group receiving methylprednisolone treatment and the observation group receiving methylprednisolone combined with GM1. The e ective rate of treatment, time of normal muscle strength recovery, walk on the ground, and hospital stay were compared. The changes in the American Spinal Injury Association (ASIA) score, activity of daily living (ADL), serum in ammatory factors, oxidative stress factor levels, and adverse reactions were recorded. Results: The e ective rate of clinical e cacy of the observation group was 92.50%, surpassing the control group's which was 75.00% (Ç2 = 4.501, p = 0.034). The observation group had a shorter recovery time for muscle strength, walking time, and hospital stay compared to the control group (p <0.05). After treatment, the ADL scores of both groups were higher than before treatment, and the degree of increase in the observation group was higher than the control group (p <0.05). The levels of serum tumour necrosis factor-± (TNF-±) and interleukin-8 (IL-8) for all patients were signi cantly reduced, with the observation group showing a more signi cant decrease (p <0.05). There was a notable increase in glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) levels in both groups, while the levels of malondialdehyde (MDA) decreased signi cantly. GSH-Px, SOD, and MDA levels were signi cantly greater in the observation group (p <0.05). Conclusion: The combination of methylprednisolone and MG1 treatment of SCI can signi cantly reduce the in ammatory response and improve clinical efficacy.
Publication Details
Page(s) 238-241
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
oxidative stress, Spinal cord injury, Methylprednisolone, In ammatory indicators, Ganglioside
References
Wang W,Zuo B,Liu H,Cui L H .2019 .Intermittent injection of methylprednisolone sodium succinate in the treatment of cervical spinal cord injury complicated with incomplete paraplegia. Pak J Med Sci, 10(1) : 141-5.
Ding W,Hu S,Wang P,Kang H,Peng R,Dong Y .2022 .Spinal cord injury: The global incidence, prevalence, and disability from the global burden of disease study 2019. Spine (Phila Pa, 10(21) : 1532-40.
Yu M,Wang Z,Wang D,Aierxi M,Wang Z,Y Z .2023 .Oxidative stress following spinal cord injury: From molecular mechanisms to therapeutic targets. J Neurosci Res, 10(10) : 1538-54.
Liu YX,Liu Q,Deng R .2018 .Curativc e ect of monosialoganglioside GM1 on postoperative cognitive dysfunction in the patients with craniocerebral trauma: A metaanalysis. Hainan Med J, 29(9) : 1311-5.
Shijie Zhang .2008 .Clinical spinal surgery. , : 66-68.
Liu Z,Yao X,Jiang W,Li W,Zhu S,Liao C . .Advanced oxidation protein products induce microglia-mediated neuroin ammation via MAPKs-NF-ºB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuro-, : .
Kirshblum S,Snider B,Eren F,Guest J .2020 .Characterising natural recovery after traumatic spinal cord injuryJ. Neurotrauma, 7473(9) : 1267-84.
Hu X,Xu W,Ren Y,Wang Z,He X,Huang R .2023 .Spinal cord injury: Molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther, 10(1) : 245.
Guo S,Redenski I,Levenberg S. .1872 .Spinal cord repair: From cells and tissue engineering to extracellular vesicles. Cells, 10(8) : .
Sterner RC,Sterner RM .2022 .Immune response following traumatic spinal cord injury: Pathophysiology and therapies. Front Immunol, 1084101 : 1084101.
Yao X,Sun C,Fan B,Zhao C,Zhang Y,Duan H .2020 .Neurotropin exerts neuroprotective e ects after spinal cord injury by inhibiting apoptosis and modulating cytokines. J Orthop Translat, 02 : 74-83.
Choi SH,Sung CH,Heo DR,Jeong SY,Kang CN .2020 .Incidence of acute spinal cord injury and associated complications of methylprednisolone therapy: A national population-based study in South Korea. Spinal Cord, 10(2) : 232-7.
Guha L,Kumar H .2023 .Drug repurposing for spinal cord injury: Progress towards therapeutic intervention for primary factors and secondary complications. Pharmaceut Med, 10(6) : 463-90.
Guo Z. Ganglioside .2023 .GM1 and the central nervous system. Int J Mol Sci, 10(11) : 9558.
Chiricozzi E,Lunghi G,Di Biase E,Fazzari M,Sonnino S .2020 .GM1 ganglioside is a key factor in maintaining the mammalian neuronal functions avoiding neurodegeneration. Int J Mol Sci, 10(3) : 868.
Jiang X,Liu X,Yu Q,Shen W,Mei X,Tian H .2021 .Functional resveratrol-biodegradable manganese doped silica nanoparticles for the spinal cord injury treatment. Mater Today Bio, 100177 : 100177.
Liu Z,Tu K,Zou P,Liao C,Ding R,Huang Z .2023 .Hesperetin ameliorates spinal cord injury by inhibiting NLRP3 in ammasome activation and pyroptosis through enhancing Nrf2 signaling. Int Immunopharmacol, 110103 : 110103.
0

Citations

0

Downloads

99

Views